12.5/500 322M (Kazano 12.5 mg / 500 mg)
Generic Name: alogliptin/metformin
Pill imprint 12.5/500 322M has been identified as Kazano 12.5 mg / 500 mg.
Kazano is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Kazano 12.5 mg / 500 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 12.5/500 322M
- 12.5 mg / 500 mg
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Takeda Pharmaceuticals America, Inc.
More about Kazano (alogliptin / metformin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 1 Review – Add your own review/rating
- Drug class: antidiabetic combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.